|
Title: A patient is undergoing a cytotoxic chemotherapy regimen for the treatment of stage III lung cancer. ... Post by: Charlesnep on Mar 6, 2019 A patient is undergoing a cytotoxic chemotherapy regimen for the treatment of stage III lung cancer. What effect will this regimen likely have on the patient's hemostatic function?
A)The patient's platelet count will decline. B)The patient will be at increased risk of deep vein thrombosis. C)The patient will require prophylactic heparin. D)The patient will likely experience thrombocytosis. Title: A patient is undergoing a cytotoxic chemotherapy regimen for the treatment of stage III lung cancer. ... Post by: jonnyjon on Mar 6, 2019 Content hidden
|